Proboxis Biotechnology Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 1

Proboxis Biotechnology General Information

Description

Developer of a vaccine technology platform designed to prevent mosquito-borne flavivirus diseases. The company offers chimeric vaccine production, insect-cell biotechnology, flavivirus prevention tools, bioprocess scale-up, and Japanese encephalitis vaccine candidates, enabling public health organizations to rapidly adapt to emerging viral threats using non-infectious virus particles.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Sydney, New South Wales
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Sydney, New South Wales
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proboxis Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 21-Sep-2026 $1.5M Completed Startup
To view Proboxis Biotechnology’s complete valuation and funding history, request access »

Proboxis Biotechnology Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biointelect Accelerator/Incubator
To view Proboxis Biotechnology’s complete investors history, request access »

Proboxis Biotechnology FAQs

  • When was Proboxis Biotechnology founded?

    Proboxis Biotechnology was founded in 2026.

  • Where is Proboxis Biotechnology headquartered?

    Proboxis Biotechnology is headquartered in Sydney, Australia.

  • What industry is Proboxis Biotechnology in?

    Proboxis Biotechnology’s primary industry is Drug Discovery.

  • Is Proboxis Biotechnology a private or public company?

    Proboxis Biotechnology is a Private company.

  • What is Proboxis Biotechnology’s current revenue?

    The current revenue for Proboxis Biotechnology is .

  • How much funding has Proboxis Biotechnology raised over time?

    Proboxis Biotechnology has raised $1.5M.

  • Who are Proboxis Biotechnology’s investors?

    Biointelect has invested in Proboxis Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process